Latest News
Lab Thread launches unified digital platform for biological research workflows
...
Curocell secures full approval for RIMQARTO to enter CAR-T therapy market
30 April 2026 - Cell therapy company Curocell (KOSDAQ:372320) announced on Thursday that RIMQARTO Inj. (anbalcabtagene autoleucel) has received full regulatory approval from South Korea's Ministry of Food and Drug Safety, marking the first comme...
Xbrane resubmits FDA application for ranibizumab biosimilar after facility remediation
30 April 2026 - Swedish biosimilars developer Xbrane Biopharma AB (STO:XBRANE) said on Thursday that it has resubmitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for its biosimilar candidate to LUCENTIS (ran...
Sprout Pharmaceuticals named one of TIME's most influential health and life sciences companies of 2026
30 April 2026 - TIME magazine has named women's health specialist Sprout Pharmaceuticals among 10 organisations globally shaping the future of health and life sciences.This recognition follows a defining period of momentum for Sprout and its fla...
Neurocrine Biosciences reports publication of new research establishing clinically meaningful improvement threshold for TDIS
30 April 2026 - US biopharmaceutical company Neurocrine Biosciences Inc (Nasdaq:NBIX) announced on Wednesday the publication of new peer-reviewed research in The Journal of Clinical Psychiatry, demonstrating how the Tardive Dyskinesia Impact Scale he...